Chronic Kidney Disease: Meeting Listing 6.05

Chronic kidney disease (CKD) can meet Blue Book Listing 6.05 when reduced kidney function is documented by specific laboratory thresholds and complicated by one of four listed problems, with every laboratory finding confirmed on at least two occasions at least 90 days apart. The Social Security Administration (SSA) publishes the listing in the genitourinary body system, 20 CFR Part 404, Subpart P, Appendix 1, and it rewards complete, well-dated lab work more than almost any other listing.

Section 6.00A explains the disorders SSA evaluates under these rules: chronic glomerulonephritis, hypertensive nephropathy, diabetic nephropathy, chronic obstructive uropathy, and hereditary nephropathies, along with nephrotic syndrome from glomerular dysfunction. The cause matters less than the level of function and the complications that follow.

The Faster Routes First: Dialysis and Transplant

Before wrestling with 6.05, claimants should know about two adjacent listings that decide many kidney cases on treatment status alone.

Listing 6.03 covers chronic kidney disease with chronic hemodialysis or peritoneal dialysis. The dialysis must have lasted, or be expected to last, at least 12 continuous months. To satisfy the evidence requirement, SSA will accept a report from an acceptable medical source describing the CKD, the current dialysis, and the expectation that it will be ongoing.

Listing 6.04 covers kidney transplant recipients, who are considered disabled for 1 year from the date of transplant. After that year, SSA evaluates the residual impairment under 6.00C2, weighing post-transplant function, rejection episodes, complications in other body systems, and treatment side effects. Section 6.00C also notes that disability may have begun before dialysis or transplant started, with onset set on the facts of the record.

Listing 6.05A: The Laboratory Thresholds

Paragraph A requires reduced glomerular filtration evidenced by one of three findings, each documented on at least two occasions at least 90 days apart during a consecutive 12-month period:

• Serum creatinine of 4 mg/dL or greater.
• Creatinine clearance of 20 ml/min or less.
• Estimated glomerular filtration rate (eGFR) of 20 ml/min/1.73m2 or less.

Section 6.00B2 explains that the eGFR estimates the kidneys' filtering capacity using serum creatinine plus variables such as age, sex, and body size, and that SSA considers eGFR findings when they appear in the evidence. A single abnormal result is not enough, because kidney function can dip temporarily during an acute illness. The two-occasion, 90-day-apart structure is what turns a lab value into proof of chronic impairment, consistent with section 6.00B1, which generally requires evidence covering at least 90 days.

Dated lab reports from two separate draws, ideally with the eGFR, creatinine, and clearance calculations printed on them, are therefore the backbone of a 6.05 claim. Missing dates or a single isolated value are among the most common reasons kidney claims are delayed for development.

Listing 6.05B: The Required Complication

Paragraph A alone never carries the listing. Paragraph B requires at least one of four complications, defined in section 6.00C.

Renal osteodystrophy. Bone degeneration from the chronic kidney disease mineral and bone disorder, with severe bone pain and imaging studies documenting abnormalities such as osteitis fibrosa, osteomalacia, or pathologic fractures. Severe bone pain, under 6.00C3, means frequent or intractable pain that interferes with physical activity or mental functioning.

Peripheral neuropathy. Under 6.00C4, the toxins that accumulate when kidneys fail can damage motor or sensory nerves, causing pain, numbness, tingling, and weakness. The neuropathy must be a severe impairment expected to last at least 12 continuous months.

Fluid overload syndrome. Excess sodium and water retention producing vascular congestion. Under 6.05B3, this must be documented by either diastolic blood pressure of 110 mm Hg or higher despite at least 90 consecutive days of prescribed therapy, shown by at least two measurements at least 90 days apart within a 12-month period, or signs of vascular congestion or anasarca despite at least 90 consecutive days of prescribed therapy, documented on at least two occasions at least 90 days apart. Section 6.00C5 lists the qualifying signs: congestive heart failure, pleural effusion, ascites, hypertension, fatigue, shortness of breath, and peripheral edema, with anasarca meaning generalized massive swelling.

Anorexia with weight loss. Under 6.05B4, diminished appetite with weight loss shown by a body mass index of 18.0 or less, calculated on at least two occasions at least 90 days apart within a consecutive 12-month period. Section 6.00C7 notes that SSA calculates BMI using the formulas in the digestive disorders body system (5.00).

Listing 6.09: Complications Requiring Hospitalization

Claimants whose function levels do not reach 6.05A may still qualify under Listing 6.09, which requires at least three hospitalizations within a consecutive 12-month period for complications of CKD, occurring at least 30 days apart, with each hospitalization lasting at least 48 hours including emergency department hours immediately before admission. Section 6.00C8 gives examples of qualifying complications: stroke, congestive heart failure, hypertensive crisis, or acute kidney failure requiring a short course of hemodialysis.

Evidence SSA Needs for a Kidney Claim

Section 6.00B1 calls for reports of clinical examinations, treatment records, and documentation of the response to treatment, alongside the lab findings. If a kidney or bone biopsy was performed, SSA needs the pathology report, or a statement from an acceptable medical source verifying the biopsy and describing its results.

The practical checklist for a 6.05 claim is short but strict:

• Two or more dated lab reports at least 90 days apart showing the same qualifying threshold.
• Treatment records covering the full 12-month period relied upon.
• Documentation of the paragraph B complication, with blood pressure logs, edema descriptions, nerve examination findings, bone imaging, or BMI measurements as applicable.

If the Listing Is Not Met

Section 6.00D governs the fallback. SSA first checks listings in other body systems, since kidney disease frequently couples with cardiovascular and neurological impairments. It then considers medical equivalence under 20 CFR 404.1526, weighing the combined effects of multiple impairments. If no listing is met or equaled, the claim proceeds to residual functional capacity (RFC) under 20 CFR 404.1545 and the fourth and fifth steps of the sequential evaluation under 20 CFR 404.1520, where fatigue, treatment schedules, and the medical-vocational guidelines in 20 CFR Part 404, Subpart P, Appendix 2 determine the outcome.

NonMedical Requirements in 2026

SSDI eligibility also depends on insured status under 20 CFR 404.130, generally 20 work credits in the 10 years ending with onset. In 2026, one work credit is credited for each $1,860 in covered earnings, up to four per year. Earnings above the substantial gainful activity level under 20 CFR 404.1574, which is $1,670 per month for non-blind claimants and $2,780 for statutorily blind claimants in 2026, generally results in a denial at step one.

Frequently Asked Questions

What eGFR level meets Listing 6.05 for kidney disease? Listing 6.05A accepts an estimated glomerular filtration rate (eGFR) of 20 ml/min/1.73m2 or less, documented on at least two occasions at least 90 days apart during a consecutive 12-month period. The same rule accepts a serum creatinine of 4 mg/dL or greater or a creatinine clearance of 20 ml/min or less.

Does dialysis automatically qualify you for SSDI? Yes, under Listing 6.03, chronic kidney disease with chronic hemodialysis or peritoneal dialysis expected to last at least 12 continuous months meets the listing, and a report from an acceptable medical source describing the ongoing dialysis satisfies the evidence requirement.

Why does Listing 6.05 require two lab results 90 days apart? SSA needs evidence that kidney function is chronically reduced rather than temporarily worse during an acute illness. Section 6.00B1 generally requires evidence covering at least 90 days, and every lab option in 6.05A must be documented on at least two occasions at least 90 days apart within a consecutive 12-month period.

This article provides general information about Social Security Disability Insurance eligibility, not legal advice. Program rules and medical criteria change over time, and all figures cited here reflect the standards in effect in 2026. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.